WELLEX gains Health Canada approval for a human trial of Papillex®, studying natural support for HPV and cervical health.

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic ...

A new study shows that while decentralized clinical trials (DCTs) are making research more accessible, they also bring ...

Artificial Intelligence (AI) is no longer just a buzzword it is transforming the way healthcare is delivered and its influence is now reaching deep into the world of clinical trials from predicting ...

Early human factors testing can reveal critical blind spots, cut medical device development costs and steer overall product ...

Results show biopsy-proven resolution of BK polyomavirus nephropathy in kidney transplant recipients No safety or ...

In this video interview, Heather Horville, solutions consultant at Greenphire, discusses how clinical teams can boost participant retention in lengthy or complex trials through strategies like ...

The first patient has been treated with InterVene’s Recana thrombectomy system for restoring patency (blood flow) in chronically obstructed deep veins and venous stents.

UK & Ireland, experts provided insights on market trends within the clinical trial industry and advice on engagement strategies.

Arquitos Capital Management gained 13.1% in Q2 2025. Learn how they turned market uncertainty into opportunity with Liquidia ...

Remote and technology-driven approach to studies makes it harder to build relationships, establish trust, understand what ...